Pathology & Laboratory Medicine

Warning message

Selective filter "Related Faculty (field_biblio_faculty) (selective)" has limited the amount of total results. Please, review you query configuration.

Publications

Filter By Faculty

Filter by Principal Investigator

2024

de Hoog S, Walsh TJ, Ahmed SA, Alastruey-Izquierdo A, Alexander BD, Arendrup MC, et al. Reply to Kidd et al., "Inconsistencies within the proposed framework for stabilizing fungal nomenclature risk further confusion". J Clin Microbiol. 2024:e0162523.

Pakula H, Omar M, Carelli R, Pederzoli F, Fanelli GN, Pannellini T, et al. Distinct mesenchymal cell states mediate prostate cancer progression. Nat Commun. 2024;15(1):363.

Venkadakrishnan VB, Presser AG, Singh R, Booker MA, Traphagen NA, Weng K, et al. Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes. Res Sq. 2024.

Kim D, Thrall MJ, Michelow P, Schmitt FC, Vielh PR, Siddiqui MT, et al. The current state of digital cytology and artificial intelligence (AI): global survey results from the American Society of Cytopathology Digital Cytology Task Force. J Am Soc Cytopathol. 2024;13(5):319-328.

Kudman S, Semaan A, Assaad MA, Gogineni S, M Martin L, Mathew S, et al. Optimization of Fluorescence In Situ Hybridization Protocols in the Era of Precision Medicine. Curr Protoc. 2024;4(6):e1093.

Javdan B, Marwaha S, Magro C, Wassef C. Pink Papules on the Cheek. Cutis. 2024;113(1):10-17.

Cavallaro J, Singha S, Chakrabarti B, Gopalakrishnan E, Harshan M, Pramanik BK, et al. Symptomatic infratentorial ependymal cyst arising from the medulla: a case report with review of literature. Neurochirurgie. 2024;70(4):101553.

Smithgall MC, Yemelyanova A, Mathew S, Gogineni S, He B, Zhang T, et al. HER2/ ERBB2 Immunohistochemical Expression and Copy Number Status in Ovarian Mucinous Tumors. Int J Gynecol Pathol. 2024;43(2):134-139.

Chan AT, Maya TR, Park C, Tak K, Liberman N, Jain RH, et al. Incremental Utility of First-Pass Perfusion CMR for Prognostic Risk Stratification of Cancer-Associated Cardiac Masses. JACC Cardiovasc Imaging. 2024;17(2):128-145.

Rowdo FP, Xiao G, Khramtsova GF, Nguyen J, Martini R, Stonaker B, et al. Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment. Cancer Lett. 2024;584:216608.